Korean J Transplant.  2023 Jun;37(2):103-108. 10.4285/kjt.23.0026.

Reoperation etiologies in the initial hospital stay after liver transplantation: a single-center study from Iran

Affiliations
  • 1Hepato-Pancreato-Biliary and Transplant Surgery, Masih Daneshvari Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran
  • 2Lung Transplantation Research Center, National Research Institute of Tuberculosis and Lung Diseases, Shahid Beheshti University of Medical Sciences, Tehran, Iran
  • 3Tracheal Diseases Research Center, National Research Institute of Tuberculosis and Lung Diseases, Shahid Beheshti University of Medical Sciences, Tehran, Iran

Abstract

Background
Liver transplantation (LT) is widely recognized as a life-saving therapy for patients with end-stage liver disease. However, due to certain posttransplant complications, reoperations or endovascular interventions may be necessary to improve patient outcomes. This study was conducted to examine reasons for reoperation during the initial hospital stay following LT and to identify its predictive factors.
Methods
We evaluated the incidence and etiology of reoperation in 133 patients who underwent LT from brain-dead donors over a 9-year period based on our experiences.
Results
A total of 52 reoperations were performed for 29 patients, with 17 patients requiring one reoperation, seven requiring two, three requiring three, one requiring four, and one requiring eight. Four patients underwent liver retransplantation. The most common cause of reoperation was intra-abdominal bleeding. Hypofibrinogenemia was identified as the sole predisposing factor for bleeding. Frequencies of comorbidities such as diabetes mellitus and hypertension did not differ significantly between groups. Among patients who underwent reoperation due to bleeding, the mean plasma fibrinogen level was 180.33±68.21 mg/dL, while among reoperated patients without bleeding, it was 240.62±105.14 mg/dL (P=0.045; standard mean difference, 0.61; 95% confidence interval, 0.19–1.03). The initial hospital stay was significantly longer for the reoperated group (47.5±15.5 days) than for the non-reoperated group (22.5±5.5 days).
Conclusions
Meticulous pretransplant assessment and postoperative care are essential for the early identification of predisposing factors and posttransplant complications. In order to enhance graft and patient outcomes, any complications should be addressed without hesitation, and appropriate intervention or surgery should not be delayed.

Keyword

Liver transplantation; Repeat surgery; Postoperative complications; Etiology

Reference

1. Nejatollahi SM, Marashi SA, Janatmakan F, Vosoghian M, Hasanzadehkiabi M, Fazel I. 2020; A single-center report on liver transplantation: first experiences from Shahid Beheshti University of Medical Sciences. Middle East J Dig Dis. 12:252–6.
2. Graziadei I, Zoller H, Fickert P, Schneeberger S, Finkenstedt A, Peck-Radosavljevic M, et al. 2016; Indications for liver transplantation in adults: recommendations of the Austrian Society for Gastroenterology and Hepatology (ÖGGH) in cooperation with the Austrian Society for Transplantation, Transfusion and Genetics (ATX). Wien Klin Wochenschr. 128:679–90. DOI: 10.1007/s00508-016-1046-1. PMID: 27590261. PMCID: PMC5052293.
3. Khungar V, Goldberg DS. 2016; Liver transplantation for cholestatic liver diseases in adults. Clin Liver Dis. 20:191–203. DOI: 10.1016/j.cld.2015.08.011. PMID: 26593299. PMCID: PMC4660247.
Article
4. Starzl TE, Iwatsuki S, Van Thiel DH, Gartner JC, Zitelli BJ, Malatack JJ, et al. 1982; Evolution of liver transplantation. Hepatology. 2:614–36. DOI: 10.1002/hep.1840020516. PMID: 6749635. PMCID: PMC2972731.
Article
5. Malek-Hosseini SA, Jafarian A, Nikeghbalian S, Poustchi H, Lankarani KB, Nasiri Toosi M, et al. 2018; Liver transplantation status in Iran: a multi-center report on the main transplant indicators and survival rates. Arch Iran Med. 21:275–82.
6. Craig EV, Heller MT. 2021; Complications of liver transplant. Abdom Radiol (NY). 46:43–67. DOI: 10.1007/s00261-019-02340-5. PMID: 31797026.
Article
7. DiNorcia J, Lee MK, Harlander-Locke M, Zarrinpar A, Kaldas FM, Yersiz H, et al. 2014; Reoperative complications after primary orthotopic liver transplantation: a contemporary single-center experience in the post-model for end-stage liver disease era. J Am Coll Surg. 219:993–1000. DOI: 10.1016/j.jamcollsurg.2014.07.005. PMID: 25127506.
Article
8. Duffy JP, Hong JC, Farmer DG, Ghobrial RM, Yersiz H, Hiatt JR, et al. 2009; Vascular complications of orthotopic liver transplantation: experience in more than 4,200 patients. J Am Coll Surg. 208:896–903. DOI: 10.1016/j.jamcollsurg.2008.12.032. PMID: 19476857.
Article
9. Moghadamyeghaneh Z, Alameddine M, Jue JS, Guerra G, Selvaggi G, Nishida S, et al. 2018; A nationwide analysis of re-exploration after liver transplant. HPB (Oxford). 20:216–21. DOI: 10.1016/j.hpb.2017.08.024. PMID: 29129486.
Article
10. Khalaf H. 2010; Vascular complications after deceased and living donor liver transplantation: a single-center experience. Transplant Proc. 42:865–70. DOI: 10.1016/j.transproceed.2010.02.037. PMID: 20430192.
Article
11. Ertel AE, Wima K, Chang AL, Hoehn RS, Hohmann SF, Edwards MJ, et al. 2016; Risk of reoperation within 90 days of liver transplantation: a necessary evil? J Am Coll Surg. 222:419–28. DOI: 10.1016/j.jamcollsurg.2016.01.007. PMID: 26905185.
Article
12. Elsabbagh AM, Girlanda R, Hawksworth J, Pichert MD, Williams C, Pozzi A, et al. 2018; Impact of early reoperation on graft survival after liver transplantation: univariate and multivariate analysis. Clin Transplant. 32:e13228. DOI: 10.1111/ctr.13228. PMID: 29478256. PMCID: PMC6433119.
Article
13. Thompson MA, Redden DT, Glueckert L, Smith AB, Crawford JH, Jones KA, et al. 2014; Risk factors associated with reoperation for bleeding following liver transplantation. HPB Surg. 2014:816246. DOI: 10.1155/2014/816246. PMID: 25505820. PMCID: PMC4258335.
Article
14. Park C, Huh M, Steadman RH, Cheng R, Hu KQ, Farmer DG, et al. 2010; Extended criteria donor and severe intraoperative glucose variability: association with reoperation for hemorrhage in liver transplantation. Transplant Proc. 42:1738–43. DOI: 10.1016/j.transproceed.2009.12.066. PMID: 20620513.
15. Liu X, Guo R, Tian J. 2022; Association of plasma fibrinogen levels on postoperative day 1 with 2-year survival of orthotopic liver transplantation for HBV-related HCC. Lab Med. 53:30–8. DOI: 10.1093/labmed/lmab052. PMID: 34268570.
16. Bonnet S, Sauvanet A, Bruno O, Sommacale D, Francoz C, Dondero F, et al. 2010; Long-term survival after portal vein arterialization for portal vein thrombosis in orthotopic liver transplantation. Gastroenterol Clin Biol. 34:23–8. DOI: 10.1016/j.gcb.2009.05.013. PMID: 19643558.
17. Schwope RB, Margolis DJ, Raman SS, Kadell BM. 2010; Portal vein aneurysms: a case series with literature review. J Radiol Case Rep. 4:28–38. DOI: 10.3941/jrcr.v4i6.431. PMID: 22470738. PMCID: PMC3303410.
18. Pérez-Saborido B, Pacheco-Sánchez D, Barrera-Rebollo A, Asensio-Díaz E, Pinto-Fuentes P, Sarmentero-Prieto JC, et al. 2011; Incidence, management, and results of vascular complications after liver transplantation. Transplant Proc. 43:749–50. DOI: 10.1016/j.transproceed.2011.01.104. PMID: 21486590.
Article
19. Silva MA, Jambulingam PS, Gunson BK, Mayer D, Buckels JA, Mirza DF, et al. 2006; Hepatic artery thrombosis following orthotopic liver transplantation: a 10-year experience from a single centre in the United Kingdom. Liver Transpl. 12:146–51. DOI: 10.1002/lt.20566. PMID: 16382467.
Article
20. Parrilla P, Sánchez-Bueno F, Figueras J, Jaurrieta E, Mir J, Margarit C, et al. 1999; Analysis of the complications of the piggy-back technique in 1,112 liver transplants. Transplantation. 67:1214–7. DOI: 10.1097/00007890-199905150-00003. PMID: 10342311.
Article
21. Hejazi Kenari SK, Zimmerman A, Eslami M, F Saidi R. 2014; Current state of art management for vascular complications after liver transplantation. Middle East J Dig Dis. 6:121–30.
22. Lerut J, Tzakis AG, Bron K, Gordon RD, Iwatsuki S, Esquivel CO, et al. 1987; Complications of venous reconstruction in human orthotopic liver transplantation. Ann Surg. 205:404–14. DOI: 10.1097/00000658-198704000-00011. PMID: 3551857. PMCID: PMC1492747.
Article
23. Thethy S, Thomson BN, Pleass H, Wigmore SJ, Madhavan K, Akyol M, et al. 2004; Management of biliary tract complications after orthotopic liver transplantation. Clin Transplant. 18:647–53. DOI: 10.1111/j.1399-0012.2004.00254.x. PMID: 15516238.
Article
24. Hendriks HG, van der Meer J, de Wolf JT, Peeters PM, Porte RJ, de Jong K, et al. 2005; Intraoperative blood transfusion requirement is the main determinant of early surgical re-intervention after orthotopic liver transplantation. Transpl Int. 17:673–9. DOI: 10.1007/s00147-004-0793-5. PMID: 15717214.
Article
25. Azzam AZ, Tanaka K. 2017; Biliary complications after living donor liver transplantation: a retrospective analysis of the Kyoto experience 1999-2004. Indian J Gastroenterol. 36:296–304. DOI: 10.1007/s12664-017-0771-3. PMID: 28744748.
Article
26. Klein KB, Stafinski TD, Menon D. 2013; Predicting survival after liver transplantation based on pre-transplant MELD score: a systematic review of the literature. PLoS One. 8:e80661. DOI: 10.1371/journal.pone.0080661. PMID: 24349010. PMCID: PMC3861188.
Article
Full Text Links
  • KJT
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr